Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell Function  by Song, Xiaomin et al.
Cell Reports
ArticleStructural and Biological Features
of FOXP3 Dimerization Relevant
to Regulatory T Cell Function
Xiaomin Song,1,3,6 Bin Li,2,3,6 Yan Xiao,3 Chunxia Chen,3 Qiang Wang,3,7 Yujie Liu,3 Alan Berezov,3,8 Chen Xu,4 Yayi Gao,2
Zhiyuan Li,2 Shiaw-Lin Wu,5 Zheng Cai,3 Hongtao Zhang,3 Barry L. Karger,5 Wayne W. Hancock,3 Andrew D. Wells,3
Zhaocai Zhou,1,* and Mark I. Greene3,*
1State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China 200031
2Key Laboratory of Molecular Virology & Immunology, Institute Pasteur of Shanghai, Shanghai Institutes for Biological Sciences,
Chinese Academy of Sciences, Shanghai, China 200031
3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
4Rosentiel Basic Medical Research Center, Brandeis University, Waltham, MA 02453, USA
5Barnett Institute, Northeastern University, Boston, MA 02115, USA
6These authors contributed equally to this work
7Present address: Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center,
Los Angeles, CA 90048, USA
8Present address: Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
*Correspondence: zczhou@sibs.ac.cn (Z.Z.), greene@reo.med.upenn.edu (M.I.G.)
DOI 10.1016/j.celrep.2012.04.012SUMMARY
FOXP3 is a key transcription factor for regulatory
T cell function. We report the crystal structure of
the FOXP3 coiled-coil domain, through which a loose
or transient dimeric association is formed andmodu-
lated, accounting for the activity variations intro-
duced by disease-causing mutations or posttransla-
tional modifications. Structure-guided mutagenesis
revealed that FOXP3 coiled-coil-mediated homodi-
merization is essential for Treg function in vitro and
in vivo. In particular, we identified human FOXP3
K250 and K252 as key residues for the conforma-
tional change and stability of the FOXP3 dimer, which
can be regulated by protein posttranslational modifi-
cations such as reversible lysine acetylation. These
studies provide structural and mechanistic explana-
tions for certain disease-causing mutations in the
coiled-coil domain of FOXP3 that are commonly
found in IPEX syndrome. Overall, the regulatory
machinery involving homooligomerization, acetyla-
tion, and heteroassociation has been dissected,
defining atomic insights into the biological and path-
ological characteristics of the FOXP3 complex.
INTRODUCTION
Regulatory T cells (Treg) play an important role in adaptive
immune regulation by suppressing antiself responses of diverse
immune cell populations including CD4+ effector T cells, CD8+
cytotoxic T cells, antigen-presenting cells, and B cells (Qin
et al., 1993; Rudensky and Campbell, 2006; Sakaguchi et al.,
1995, 2006; Schwartz, 2005). The forkhead/winged-helix tran-scriptional factor FOXP3 is selectively expressed in Tregs and
functions as a dominant regulator of the development and func-
tion of this population of cells (Fontenot et al., 2003; Hori et al.,
2003; Khattri et al., 2003). Mutations of FOXP3 lead to loss of
Treg suppressor function (Lin et al., 2007) and are responsible
for causing ‘‘X-linked autoimmunity and allergic dysregulation’’
(XLAAD) syndrome or ‘‘Immunodysregulation, polyendocrinop-
athy and enteropathy, X-linked’’ (IPEX) syndrome, a fatal reces-
sive immune disorder in humans (Bennett et al., 2001; Chatila
et al., 2000; Gambineri et al., 2003; Wildin et al., 2001). In scurfy
mice, a frameshift mutation in the FOXP3 gene also results in
defects in T cell tolerance, characterized with excessive CD4+
T cells proliferation, extensive leukocyte infiltration into certain
tissues, and systemic elevation of numerous cytokines (Bennett
et al., 2001; Brunkow et al., 2001; Godfrey et al., 1991; Wildin
et al., 2001).
FOXP3 associates with a number of transcriptional factors
including NFAT (Wu et al., 2006), NF-kB (Bettelli et al., 2005),
AML1/Runx-1 (Ono et al., 2007), and RORa (Ziegler, 2006) to
function as a negative regulator of gene transcription. We and
others have previously characterized FOXP3 as a protein species
that is part of several dynamic supramolecular complexes in
which FOXP3 interacts with the histone acetyltransferase
(HAT), TIP60, p300, and histone deacetylases (HDAC), HDAC7,
HDAC1, and transiently with HDAC9, in Tregs (Li et al., 2007a;
van Loosdregt et al., 2010; Xiao et al., 2010). FOXP3 forms
a dynamic protein complex with these proteins and can differen-
tially regulate gene transcription in a site-dependent manner.
FOXP3 binding to the promoter region can lead to either histone
deacetylation and transcription repression, or histone acetyla-
tion and transcription activation (Chen et al., 2006).
Dimerization of FOXP3 ensemble is required for its function as
a transcriptional regulator (Chae et al., 2006; Li et al., 2007b;
Lopes et al., 2006). The leucine zipper of FOXP3 is necessary
and sufficient to mediate both homoassociation (Chae et al.,Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authors 665
2006; Li et al., 2007b; Lopes et al., 2006) and heteroassociation
with FOXP1 (Wang et al., 2003). Although the forkhead domain
alone may bind to DNA in vitro (Bandukwala et al., 2011; Stroud
et al., 2006), the disease-associated mutations of the leucine
zipper domain disrupting FOXP3 dimerization can substantially
reduce the binding of FOXP3 to promoter regions in vivo (Chae
et al., 2006; Li et al., 2007b; Lopes et al., 2006). Moreover, the
leucine zipper is also important for the interaction between
histone H1.5 and FOXP3, which cooperatively repress inter-
leukin (IL)-2 transcription in human T cells (Mackey-Cushman
et al., 2011). These findings indicate that the FOXP3 protein
ensemble, as well as its DNA binding properties, could bemodu-
lated through oligomerization of the leucine zipper region.
However, the molecular and atomic mechanism by which the
FOXP3 dimer is regulated remains undefined.
In this study, we structurally characterized the FOXP3-Zinc
finger and leucine zipper (FOXP3-ZL) domain and further re-
vealed its functional and pathological relevance. In particular,
we identified two lysine residues in the leucine zipper region as
the critical sites for regulation of the FOXP3 homodimer.
Alterations and modifications of these lysine residues result in
changes in promoter occupancy, histone acetylation patterns,
IL-2 gene expression levels, and Treg suppression activity.
RESULTS
Structure of mFOXP3 Zinc Finger and Leucine Zipper
The crystal structure of the mouse FOXP3 (mFOXP3) domain
containing the zinc finger and leucine zipper region (amino acids
196–276, designated as mFOXP3 zinc finger and leucine zipper
[mFOXP3-ZL]) was resolved to 2.1 A˚ resolution. The amino
terminal region (V197-E209) corresponding to the zinc finger
loop was poorly defined in the crystal structure. Based on the
well-determined part corresponding to the zinc finger helix
region, a complete FOXP3 zinc finger was modeled using the
five-finger structure (Protein Data Bank [PDB] code 2GLI) (Pavle-
tich and Pabo, 1993) as a homologous template.
The structure defines amino acids V197-L223 as a zinc finger
motif, and D224-K262 as the leucine zippermotif (Figure 1A). The
zinc finger is immediately adjacent to the leucine zipper, con-
necting its a helix directly to that of the leucine zipper, producing
an extended single long helix. The zinc atom is coordinated by
residues C198, C203, H216, H221, and in part by D220.
The zinc finger motif is not directly involved in dimerization,
while the leucine zipper mediates intermolecular interactions,
consistent with biochemistry showing that FOXP3 may dimerize
via this region. The coiled coil has a minimum size of only four
heptad repeats (Figures 1A and 1B). Its a helices wind around
each other with an average pitch of 165 A˚ [calculated by using
TWISTER (Strelkov and Burkhard, 2002)], in contrast to the
146 A˚ pitch observed for the prototypical coiled-coil tropomy-
osin structure (Brown et al., 2005). The distance between the
helical axes varies by less than 0.66 A˚.
Homodimerization of FOXP3 via an Unusual Antiparallel
Coiled Coil
The mFOXP3-ZL homodimer features an unusual two-stranded
anti-parallel a-helical coiled coil with a perfect 2-fold symmetry,666 Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authorsresulting in two identical halves (K228-Q243 of subunit A paired
with Q243-H258 of subunit B, versus Q243-H258 of subunit
A paired with K228-Q243 of subunit B) (Figures 1A, S1, and S2).
The two equivalent halves start respectively from the two distal
ends of the elongated dimer andmeet at the center core residues
L241andL245,where the 2-fold axis and the coiled-coil superhe-
lical axis intersect. Each half contains four pairs of core residues:
C231-M255 (a-position), Q234-L252 (d-position), V238-E248
(a-position), and L241-L245 (d-position). Strikingly, two out of
the four pairs contain polar amino acids, which is rarely observed
in coiled-coil core packing. In order to maintain the ‘‘knobs-into-
holes’’ stacking pattern, the polar core residues Q234 and E248
turn the tips of their side chains away from the core, creating
a unique conformation that favors an intersubunit hydrogen
bonding essential for FOXP3 dimerization (Figures 1C and 1F).
The mFOXP3-ZL coiled coil is stabilized by a number of
electrostatic interactions including four hydrogen bonds and
two salt bridges. For example, the IPEX relevant residue K249
(equivalent to K250 of human FOXP3) and the breast cancer
relevant residue E242 (equivalent to E243 of human FOXP3)
form an intersubunit salt bridge right on the opposite side of
the Q234-E248 intersubunit pairing (Figure 1D). The interface
accessible surface area of mFOXP3 coiled coil is 966 A˚2 or
16% of total, which classifies the mFOXP3 homodimer as a
transient one when compared with an average of 1,462 A˚2 for
all determined protein dimers (1,515 A˚2 for homodimers and
1,335 A˚2 for heterodimers), and 1,005 A˚2 for all transient dimers
(1,153 A˚2 for strong ones and 693 A˚2 for weak ones)(Reynolds
et al., 2009). The empty space on the dimeric interface is
260 A˚3, corresponding to substantial packing holes found
near to core residues L241 and L245 (Figures 1D and 1E). These
features indicate that the FOXP3 coiled coil is rather flexible and
the homodimeric association is dynamic.
Sequence alignment of the coiled-coil motifs from the FOXP
subfamily revealed an almost identical core, including the two
polar residues at the d-position corresponding to mFOXP3
Q234 and E248 (Figure 1B). However, the molecular surface of
the mFOXP3 homodimer shows a singularly high percentage of
hydrophobic residues at b, c, and g positions, which is unex-
pected for coiled-coil structures. The three-dimensional arrange-
ment reveals that these hydrophobic residues (specifically L222,
A229, L232, L233, V237, L247, A254, and A257) form a stretch
spanning the surface of the coiled coil (Figures 1B and S4).
Mutational Analysis of Interface Residues and Minimum
Region for FOXP3 Homodimerization
Based on the mFOXP3 dimer structure, mutagenesis of full-
length human FOXP3 was used to probe the homointeracting
contribution of individual residues (Figure 1F). Of note, several
IPEXmutations including L242P, DelK250, and DelE251 (equiva-
lent to mFOXP3 L241P, DelK249, and DelE250, respectively)
are found in the coiled-coil region, but with disparate three-
dimensional positioning. In the mFOXP3 coiled-coil structure,
L241 is a core residue (d position) right on the dimeric interface;
K249 is an interface-flanking residue (e position) that forms a
hydrogen bond with E242 from the opposing subunit; yet E250
is a noninterface residue sandwiched by K249 and K251 (Figures
1C–1E). Mutation or deletion of either L241 or K249 would
Figure 1. FOXP3 Coiled-Coil-Mediated Dimeriza-
tion
(A) FOXP3-ZL forms an antiparallel dimer with a crystallo-
graphic 2-fold symmetry. Shown (top) is a structure image
viewed along the 2-fold axis of mFOXP3-ZL. The coiled-
coil pitch was plotted against residue number. Highlighted
in bold are residues at a or d position of the coiled coil.
Note that both Q234 and E248 at the coiled-coil core are
nonhydrophobic residues.
(B) Protein sequence of human and mouse FOXP1,
FOXP2, and FOXP3 were aligned. Coiled-coil registering
and residue numbering were labeled according to the
mouse FOXP3. Note that core residues Q234 and E248
forming intersubunit hydrogen bond are highly conserved,
but K251 is unique for FOXP3.
(C–E) Residues of particular interest on the mFOXP3-ZL
dimeric interface were highlighted. Red dash line repre-
sents salt bridge or hydrogen bond. Black arrow repre-
sents packing holes on the interface. (C) The side chain of
K251 interacts with and holds up the side chain of E248
through an intrasubunit hydrogen bond. As such, the side
chains of the core resides Q234 and E248 form an inter-
subunit hydrogen bond. (D) E242 and K249 form inter-
subunit hydrogen bond to stabilize the coiled coil. (E) The
dimeric packing of FOXP3 at the symmetric center (around
residue L241) leaves apparent hole on the interface.
(F) The homoassociation of wild-type and mutant human
FOXP3 molecules by immunoblotting in the context of
full-length proteins. Note that single mutant K251D
disrupts FOXP3 coiled coil.
See also Figures S1 and S2.directly affect dimerization, while deletion of E250would alter the
conformation of K249 and K251 to also affect dimerization.
We found that mutating L241 to a proline, or deletion of K249
disrupted FOXP3 homoassociation (Figure 1F). By contrast,
mutation of residues L223, K226, and A229, which are not
located on the dimeric interface, did not disrupt FOXP3 homo-
association. Mutation of another core residue (a position) V237Cell Reports 1,with an isoleucine structurally preserved the
coiled-coil packing and also did not disrupt
FOXP3 homoassociation.
Mutation of K251, a lysine residue involved in
an interaction network essential for FOXP3
dimerization (Figure 1C), to arginine, which is
found in other members of the FOXP subfamily
(Figure 1B), only slightly reduced FOXP3 homo-
association (Figure 3A). K249R and K251R
double mutations had little effect on dimeriza-
tion. However, mutations K251Q (mimicking
acetylation) and K251D reduced FOXP3 homo-
association respectively in these biochemical
studies. We propose the reduction of FOXP3
homodimers occurs through modulation of the
intersubunit hydrogen bond formed between
Q234 and E248 (Figure 1C, 1F, and 3A). These
observations indicate that the noncore residue
K251, which is unique to the FOXP3 molecule,
plays a role in regulating the stability of the
FOXP3 homodimer.Structure-based mutational analysis further revealed that
a minimum of four haptad repeats (C231LLQREV; VQSLEQQ;
LELEKEK; LGAMQAH258) is required for the FOXP3 dimer forma-
tion. Removal of the core residues (a or d position: C231 and
M255) from the coiled-coil terminal haptad repeats disrupted
the FOXP3 dimer as shown by the FOXP3 truncation mutant
amino acids (aa) 1–254; while the aa 1–258 truncation mutant665–675, June 28, 2012 ª2012 The Authors 667
Figure 2. Lysine 251 in the Leucine Zipper Is
Required for FOXP3 Function
(A) Primary murine CD4+ T cells were transduced
with empty MIGR1 retrovirus (left panel, EV)
or MIGR1 encoding wild-type, murine FOXP3
(middle panel, WT) or the lysine 251 deletion
mutant of murine FOXP3 (right panel, delK251).
Greater than 95% of T cells were transduced as
judged by expression of the tailless NGFR
reporter, and >90% of cells transduced with
FOXP3 constructs expressed FOXP3 protein.
(B–D) Cells were restimulated for 4 hr with plate-
bound anti-CD3/CD28 and assessed for IL-2
secretion by ELISA (B), and FOXP3 binding (C),
and histone acetylation (D) at the endogenous IL-2
promoter was assessed by ChIP analysis.
(E) CD4+ T cells transduced with wild-type
FOXP3 (dark gray squares), the 251K deletion
mutant (light gray circles), or empty vector (open
triangle) were assessed for their capacity to
suppress the proliferation of naive CD4+CD25
T cells in an in vitro Treg assay as compared to
purified CD4+CD25+ Treg as a positive control
(open squares). Data are depicted as the percent
inhibition of CD4+CD25 T cell division observed
in the absence of added Treg.can still form dimers, as does wild-type FOXP3 (Figure 3A).
Structure wise, the truncation mutant aa 1–254 would also lack
the intersubunit salt bridge formed by Q256 and R235, and
would lose a pivotal core-packing residue M255. M255’s side
chain contributes to maintenance of the central conformational
network formed by residues K251, Q234, and E248 (Figure 1C).
Lysine 251’s Role in FOXP3 Coiled-Coil-Mediated
Dimerization in Treg Cells
Since K251 has been highlighted as a unique residue critical
for FOXP3 homodimerization, we then expressed wild-type
mFOXP3 and mutants of mFOXP3 lacking lysine 251 (delK251)
in primary murine CD4+ T cells to verify its functional relevance
(Figure 2A). Wild-type mFOXP3 repressed il2 gene expression
by activated T cells (Figure 2B), and this was associated
with direct occupancy of mFOXP3 and deacetylation of nucleo-
somes at the il2 promoter (Figures 2B and 2C). However, the
delK251 mutant mFOXP3 failed to repress IL-2 production (Fig-
ure 2B), and completely failed to bind and remodel the chromatin
at the endogenous il2 promoter (Figures 2B–2D), indicating
that this lysine 251 is required for proper DNA binding and tran-
scriptional regulation in vivo. Furthermore, while CD4+ T cells
transduced with wild-type mFOXP3 were able to suppress the
proliferation of naive T cells in an in vitro Treg assay (Figure 2E,
black squares), CD4+ T cells expressing the delK251 mutant
mFOXP3 exhibited a nearly complete loss of suppressive
function (Figure 2E, gray circles). These results emphasize the
functional significance of a single residue, K251, in FOXP3
homodimerization.
Acetylation of FOXP3 Leucine Zipper and Its Structural/
Functional Consequences
Mass spectrometric studies of human FOXP3 (hFOXP3) revealed
that lysine residues K250 and K252 (equivalent to mFOXP3668 Cell Reports 1, 665–675, June 28, 2012 ª2012 The AuthorsK249 and K251, respectively) are acetylated in vivo. Notably,
hFOXP3 K250 (equivalent to mFOXP3 K249) is deleted in some
IPEX patients, while K252 (equivalent to mFOXP3 K251) is
represented by arginine in other members of the FOXP family.
As mentioned, mFOXP3 K249 and K251 mediate a network of
interactions that are critical for dimerization. Specifically, the
K249 side chain forms an intersubunit salt bridge with the side
chain of E242, while the side chain of K251 helps to uniquely
position or ‘‘hold’’ the side chain of E248, a polar residue at the
core (a position), so that it can form intersubunit hydrogen
bonding with the side chain of Q234, also a polar residue at
the core. The positive charges of both K249 and K251 are impor-
tant for this dimer-stabilizing network. As predicted from the
atomic structure, substitution of K249 and/or K251 with arginine,
which maintains positive charges, would be permissive for
dimerization of FOXP3 (Figure 3A). A K251D mutation that intro-
duces negative charges disrupts FOXP3 homodimer. In addition,
we found the K251D mutation also disrupts FOXP3-FOXP1
heterodimer formation (Figure 6). Acetylation of FOXP3 at K249
and/or K251 would neutralize the positive charges at these sites
through which the FOXP3 dimer stability is modulated. Indeed,
substitution of K251 with glutamine, which mimics acetylation,
slightly reduces FOXP3 dimerization (Figure 3A).
Residues that Guide Treg Function
Toexplore howdiscrete lysinesmodify FOXP3 function,we trans-
duced wild-type and mutant forms of mFOXP3 into conventional
murine CD4+ T cells to gauge their suppressive functions. Muta-
tion of lysines K249 and K251 to arginines exerted little effect on
FOXP3-mediated Treg function, whereas substantial impairment
of FOXP3 suppressive activity occurred with mutation to either
aspartic acid (D) or glutamine (Q) (Figure 3B).
Supportive data were also observed using in vivo assays of
the inhibitory effects of wild-type Tregs or T cells transduced
Figure 3. FOXP3 Lysine Mutations Affect Its Homoassociation and
Treg Suppressive Function
(A) Homoassociation of wild-type and K249/K251 FOXP3 mutants using
immunoprecipitation. The lysine residues K249 and K251, which could be
acetylated in vivo were substituted with arginine, aspartic acid or glutamine to
mimic the electrostatic effect introduced by posttranslational modifications.
Introduction of negative charges at K251 through aspartic acid substitution
disrupted FOXP3 homoassociation, while K251Q, which mimics acetylation,
led to decreased binding. Removal of the core residues (a or d position: C231
and M255) from the coiled-coil terminal haptad repeats disrupted the FOXP3
dimer as shown by the FOXP3 truncation mutant aa 1–254, while the aa 1–258
truncation mutant can still form dimers.
(B) In vitro suppression assay of regulatory T cells with wild-type or lysine
mutant FOXP3. To test the functional consequences of FOXP3 lysine modifi-
cations, wild-type (WT) or mutant FOXP3 was transfected into CD4+CD25
T cells by retrovirus as described. The data shown here are representative of
five separate experiments. Similar to (A), mutation of FOXP3 lysine residues
K249 and K251 to aspartic acid or glutamine substantially impaired the
suppressive activity of Tregs.
(C) In vivo suppression assay of regulatory T cells bearing WT or lysine mutant
FOXP3. Proliferation of Thy1.2+ CD4+CD25 T cells (106) alone, or in the
presence of either WT Thy1.1+ Tregs or Thy1.1+ CD4+CD25 T cells trans-
duced with WT or mutant FOXP3 (106), was assessed 7 days postintravenous
injection into RAG2/mice (threemice/group); data shown are representative
of three separate experiments.with wild-type or mutant forms of mFOXP3 on the homeostatic
proliferation of wild-type T cells. Transduction of T cells with
either wild-type FOXP3 or mutant FOXP3 (K249/251R) led to
comparable suppressive function to that of wild-type Tregs
(p > 0.05), whereas cells bearing the aspartic acid or glutaminemutations at these residues showed impaired Treg suppression
(p < 0.01) (Figure 3C). Since the lysines are post translationally
modified, extrinsic signals appear to affect Treg cell function
by charge alteration of the side chains of K249 and K251.
Alteration of the FOXP3 Acetylation Pattern by Discrete
Immune Extrinsic Signals
Various histone acetyltransferases could affect discrete lysine
residues of FOXP3. p300 for example appears to target residues
including but not limited to K250 and K252 of human FOXP3
(equivalent to mFOXP3 K249 and K251 respectively) (Figure 4).
We initially used p300 and hFOXP3 cotransfected 293T cells in
Figure 4A. While lysines other than K250 or 252 may also be
minimally acetylated, K250 and K252 are dominant but not the
exclusive targets of the p300 HAT.
We then examined effects of extrinsic signals on this type of
acetylation. CD3+ Jurkat T cells that contain several endogenous
histone acetyltransferases including Tip60, CBP, and p300
were transfected with wild-type or the hFOXP3 K250/K252R
double-mutant constructs. The transfected Jurkat cells were
then treated with transforming growth factor (TGF)-b and/or
IL-6. TGF-b treatment is known to increase the level of acety-
lated FOXP3 leading to enhanced chromatin binding of FOXP3
(Samanta et al., 2008) and this is also shown in Figures 4B and
4D. Strikingly, TGF-b treatment led to increased acetylation not
only in wild-type FOXP3, but also in K250 and K252 mutants
such as K250/K252R double-mutant cells, indicating that TGF-
b treatment leads to FOXP3 acetylation at other lysine residues
in addition to K250 and K252.
Therefore, HATs other than p300 are likely to be induced by
TGF-b and responsible for the acetylation of other sites. Interest-
ingly, we found that iTreg inhibiting and Th17 polarizing signals,
for example, TGF-b in combination with IL-6, limited acetylation
of both wild-type FOXP3 and the K250/K252R double mutant in
transfected Jurkat cells (Figure 4C). Furthermore, deletion of
K250, which would affect FOXP3 function as shown in Figure 4,
does not appear to alter the overall acetylation pattern induced
by TGF-b. Taken together, these data indicate that even though
FOXP3 acetylation is positively correlated with its activity as
thought, TGF-b does not promote FOXP3 acetylation at sites
K250 and K252, which are acetylated by p300. TGF-b promotes
FOXP3 acetylation through residues other than K250 and K252,
and acetylation of K250 and K252 is induced by extrinsic signals
other than TGF-b.
Homoclustering of FOXP3 Dimers
The molecular surface of the FOXP3 coiled-coil dimer is highly
hydrophobic when judged by its unusual surface composition:
48% nonpolar residues, in contrast with an average of 39% for
general protein dimers (Reynolds et al., 2009). Consistently,
crystal packing analysis revealed that the mFOXP3-ZL coiled-
coil dimer tends to form clusters by bundling upmultiple a helices
from distinct dimers (Figures 5A and S4). The extended hydro-
phobic stretch on the coiled-coil surface facilitates this type of
high-order packing between dimers.
There are also a number of hydrophobic and electrostatic
contacts between dimers (Figure 5A). The two neighboring
a helices from the two dimers pack symmetrically in anCell Reports 1, 665–675, June 28, 2012 ª2012 The Authors 669
Figure 4. TGF-b Promotes FOXP3 Acetylation
through Residues Other Than K250 and K252 that
Were Acetylated by p300
(A) K250 and K252 are acetylated by p300. 293T cells were
cotransfected with p300 and wild-type HA-FOXP3 or
FOXP3 mutants. Twenty-four hours after transfection,
total lysates were collected, immunoprecipitated with HA-
agarose, followed by immunoblotting with anti-Ac-K or
HA-HRP.
(B andC) Acetylation level of wild-type FOXP3 and K250R/
K252Rmutant in response to the treatment of TGF-b (B), or
TGF-b in combination with IL-6 (C). Ten million Jurkat cells
were transfected with wild-type or K250R/K252R mutant
FOXP3. Forty-eight hours after transfection, cells were
stimulated with 50 ng/ml PMA and 1 mM ionomycin, and
treatedwith 5 ng/ml TGF-b or 20 ng/ml IL-6 as indicated for
4 hr. Total lysate were then precipitatedwith anti-Ac-K and
immunoblotted with HA-HRP to check the differential
acetylation level of FOXP3 in response to TGF-b and IL-6.
(D) Increased FOXP3 acetylation in response to TGF-b is not affected by FOXP3 K250 and K252 mutations that disrupt FOXP3 dimer formation.
See also Figure S3.antiparallel mode with residue A229 in the center. A large part of
the hydrophobic stretch including residues L214, L222, K226,
A229, L233, V237, and L247 were found on the dimer-dimer
interface forming the cluster. In addition, residues E211, K215,
Q218, E225, E236, S240, Q243, Q244, E248, and K251
contribute to electrostatic stabilization of the dimer-dimer
packing in the cluster. The interface accessible surface areaFigure 5. Clustering of FOXP3 Molecules in Crystal and in Solution
(A) A dimer of the FOXP3 coiled-coil dimer observed in mFOXP3 crystals is
rendered. The dimer-based packing has a mixed nature of hydrophobic and
electrostatic interactions. Residues involved in the dimer-based clustering are
rendered in ball-and-stick models and described in the text.
(B) Electron microscopy analysis of FOXP3 molecules in solution. Black arrow
represents typical clustering corresponding to a tetrameric association.
(C) Crosslinking analysis indicated that purified recombinant FOXP3molecules
may form high molecular weight clusters in addition to monomer and dimer.
See also Figure S4.
670 Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authorsbetween the two adjacent dimers is 800 A˚2, which is compa-
rable to that of the mFOXP3-ZL coiled-coil dimer itself, repre-
senting a transient nature of the clustering interactions.
Dimer-based clustering of FOXP3 molecules might be an arti-
fact caused by crystallization. We excluded this possibility by
studying both mouse and human FOXP30s clustering propensity
in solution, by means of electron microscopy (EM) (Figure 5B)
and also by crosslinking analysis using purified recombinant
proteins (Figure 5C).While the FOXP3sample appears as a single
band on SDS-PAGE, crosslinking analyses revealed multiple
levels of clustering with the dimer being a dominant species
and small populations of species of higher order. Negative stain-
ing electron microscopy of maltose binding protein-tagged
human FOXP3 also revealed high-ordered complexes of
FOXP3 (Figure 5B, arrow).
We had previously used gel filtration analyses followed by
western blotting to show that full-length FOXP3 was present
as a mixture of monomers, dimers, tetramers and high-order
oligomers (Li et al., 2007b). Jurkat cells stably transfected with
human FOXP3 were treated with histone deacetylase inhibitors.
Nuclear fractions were isolated and proteins fractionated by
gel filtration (Figure S3). The FOXP3 complex was diminished
in overall size from the 670 Kd range leading to a substantial
fraction of the ensemble in the range 158 kDa and less, which
tends to be smaller than the size of FOXP3 tetramer. HDACi
treatment, via promoting FOXP3 acetylation, may lead to less
homoclustering of FOXP3, shifting the FOXP3 oligomerization
status toward a dimer as well as loss of certain associated
proteins.
Heterotypic Interaction of FOXP3 with FOXP1
As shown by surface plasmon resonance, FOXP1 leucine zipper
protein can form heterooligomers with FOXP3 leucine zipper
protein (Figure 6A), consistent with our previous observation
that FOXP1 colocalizes with FOXP3 at many sites within the
nucleus of human CD4+CD25+ T cells. This heteroassociation
is disrupted by the IPEX mutation of FOXP3. Moreover, knock-
down of endogenous FOXP1 in FOXP3-expressing Jurkat
Figure 6. Heteroassociation of FOXP3 with FOXP1
(A) Surface plasmon resonance (SPR) analysis of FOXP1-ZL association with
wild-type and mutant FOXP3-ZL using purified recombinant proteins. FOXP1-
ZL binds to wild-type FOXP3-ZL, but single mutation L241P or K251D or
deletion of K249 abrogated the interaction.
(B) Immunoblotting detection of FOXP1 association with FOXP3 in the context
of full-length proteins. The results are consistent with the SPR data.
See also Figure S5.T cells relieves some FOXP3-mediated repression of IL-2
production (Li et al., 2007b).
Mutations (L241P, delK249, and K251D) that disrupt mFOXP3
homodimeric interactions also impaired FOXP3-FOXP1 hetero-
association (Figures 6A and 6B). On the other hand, mutations
that maintained the FOXP3 homoassociation, including V238I
on the dimer interface, L223D, K226R, and A229C on the dimer
surface, also preserved FOXP3-FOXP1 heteroassociation
(Figures 1F and 6B). Thus, a similar interface is likely used to
mediate both homo- and heteroassociations of FOXP3 and
FOXP1. Furthermore, an arginine residue is found in FOXP1 at
the position corresponding to mFOXP3 K251 that is important
for the intersubunit hydrogen bonding between Q234 and E248
of FOXP3 (Figures 1B and 1C). Replacement of lysine with
arginine at 251 is predicted to constitutively maintain the
electrostatic interactions with residues E248 and therefore
would stabilize the FOXP1 homodimer.
DISCUSSION
FOXP3 is a transcriptional regulator acting as a component of
a dynamic multisubunit complex involved in histonemodification
and chromatin remodeling after TCR stimulation (Li et al., 2006,
2007a). Acetylated forms of FOXP3 are regulated and can be
induced by T cell receptor and TGF-b signals, while the levels
of acetylated FOXP3 are diminished by inflammatory signals.
In vivo we had previously found that a pool of acetylated formsof FOXP3 are loosely associated with chromatin (Samanta
et al., 2008). Here we define the atomic features of the dimeric
assembly of the FOXP3 coiled coil and correlates structure
with disease mutations and functional regulation.
Coiled- Coil-Mediated Dimer Is a Regulatory Structure
Important for FOXP3 Function
Our studies revealed substantial structural instability and irregu-
larities of the FOXP3 leucine zipper. For example, a high pro-
portion of polar residues were found at the core packing
(Figure 1A), and sizable holes were formed on the dimeric inter-
face passing through the hydrophobic core (Figures 1D and 1E).
Moreover, statistical analyses of accessible surface and empty
space of the dimeric interface indicated transient and dynamic
features of the FOXP3 homodimer.
The intact leucine zipper is required for DNA binding through
the FOXP3 forkhead domain (Koh et al., 2009; Li et al., 2007b).
Our current study explains at the atomic level how disruption
of homodimerization abrogates FOXP3 function in vitro and
in vivo. Based on its antiparallel conformation, the FOXP3
coiled coil also plays a role in coordinating DNA binding with
coregulator recruitment (Figure S5). Since the FOXP3 coiled
coil is not tightly assembled, we envision it to exist in a flexible
conformation able to undergo tightening to form a stable dimer
for high-affinity DNA binding upon differential posttranslational
modifications, or loosening to break apart for heteroassociation
with FOXP1. Thus, the plasticity of the FOXP3 coiled coil could
provide a regulatory basis, through which the oligomerization
status and stability of FOXP3 is controlled in a cell context
‘‘signaling’’-dependent manner.
Atomic Explanation of IPEX Disease-Causing Mutations
on FOXP3 Structure
Due to the 2-fold symmetrical conformation of the FOXP3 coiled
coil, mutation of any single residue will affect two sites of the
dimer, which therefore will enhance the biological consequence
of the mutational changes caused by diseases. The structure of
mFOXP3-ZL revealed that deletion of a single residue in the
coiled coil would break the heptad-based symmetrical packing,
resulting in mismatch of residues on the dimeric interface (Fig-
ure 1A). A network of interactions involving Q234, E242, E248,
K249, and K251 has been identified to stabilize FOXP3 homodi-
merization (Figures 1C, 1D, 7A, and 7B). Notably K251 of a helix 1
forms an intrasubunit hydrogen bond with E248, holding E248 to
further form an intersubunit hydrogen bondwith Q234 of a helix 2
(Note that a helices 1 and 2 form the mFOXP3 coiled coil). In
addition, K249 of a helix 1 directly forms an intersubunit salt
bridge with E242 of a helix 2. These observations readily explain
several reported deletions found in an IPEX patient (human
FOXP3 DelK250 and DelE251, equivalent to mFOXP3 K249
and E250) (Chatila et al., 2000; Wildin et al., 2002). Deletions of
these key residues may either directly break the E242-K249
intersubunit salt bridge, or cause a positional shift and strain or
break the Q234-E248 intersubunit hydrogen bond through
conformational ‘‘releasing’’ of E248 (Figures 7A and 7B). As
a result, these deletion mutants will disrupt the homodimeriza-
tion of FOXP3 (Figure 1F) and lead to impaired ability to repress
transcription (Figures 2 and 3) (Li et al., 2007b; Ziegler, 2006).Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authors 671
Figure 7. Structural Models of IPEX Mutations
and Lysine Acetylation of FOXP3
(A, E, G) FOXP3 lysine 251 posed the side chain of core
residue E248, which then forms intersubunit hydrogen
bond with the side chain of core residue Q234. On the
opposite side of the coiled coil, K249 forms intersubunit
salt bridge with E242.
(B) Deletion of K249 found in some IPEX patients not only
breaks its direct interaction with E242 from the opposing
a helix, but also alters the positioning of K251 relative to
E248, thus releases the side chain of E248, which then
breaks the intersubunit bonding between E248 and Q234.
(C and D) IPEX mutation L241P generates a solvent
accessible groove on the dimeric interface of FOXP3
coiled coil, making the packing hole around L241 much
larger compared with wild-type.
(E and F) The modeled acetylated form of lysine 251
(K251-Ac) neutralizes the positive charge of lysine, dis-
rupting its interaction with the side chain of E248.
Conformational variation of E248 may therefore impair its
interaction with Q234, releasing the side chain of Q234.
The resultant close contacts between L241 and E248,
Q234, and M255 may further destabilize the FOXP3
homodimerization.
(G and H) The modeled acetylated form of lysine 249
(K249-Ac) is predicted to directly disrupt the intersubunit
salt bridge between K249 and E242.Human FOXP3 L242P (equivalent to mFOXP3 L241P) is
a mutation found in an IPEX patient (Gambineri et al., 2008;
Zuo et al., 2007). It is worth noting that L241 of mFOXP3 is
located at the core position of the coiled-coil center, where the
2-fold axis passes along (Figures 1E and 7C). Variation at this
site is expected to directly alter the coiled-coil conformation
and stability, and therefore affect the regulatory function of the
FOXP3 homodimer. In the wild-type mFOXP3 coiled coil, there
is a hole near L241 and L245, indicative of a flexible nature of
the homodimer. Substitution of L241 with a proline may not
only distort the helical conformation, but also make the hole672 Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authorsnear L241 and L245 even larger. The smaller
side chain of proline would leave more empty
space in the core packing, generating a groove
(Figure 7D). One consequence of this packing is
that water molecules may pass through the
dimer interface causing instability (Figure 1F).
Modulation of FOXP3 Structure and
Function by Acetylation
Mass spectrometry and biochemical studies
identified and confirmed human FOXP3 K250
and K252, i.e., K249 and K251 of mFOXP3, as
acetylation sites in the coiled coil. Our current
structure indicates that acetylation sites K251
and K249 are electrostatically involved in the
interface network critical for FOXP3 dimeriza-
tion (Figure 7). p300 appears to target these
sites (K250 and K252 in human FOXP3) to
acetylate FOXP3. Mutational analysis of these
sites (K249-251D/Q/R) indicates that acetyla-tion appears to be important for regulating the FOXP3 dimer
formation and, suppressive activity. Recently van Loosdregt
et al. suggested that p300 could promote the acetylation level
of wild-type human FOXP3 (van Loosdregt et al., 2010).
Acetylation of K249 and/or K251 appears to modify the same
set of dimeric interactions affected by IPEX mutations. As dis-
cussed above, the key intersubunit hydrogen bond between
Q234 and E248 is dependent on the unique conformation of
the E248 side chain that is held by the side chain of K251 (Figures
7A and 7E). Acetylation of K251 will neutralize the positive
charges of its side chain and, therefore, decrease its interaction
with E248. In turn, the release of the E248 side chain will break
the intersubunit hydrogen pairing between Q234 and E248,
further releasing the side chain of Q234 (Figures 7B and 7F).
As a result, the steric tension caused by E248-L241 and Q234-
M255may further relax/destabilize the FOXP3 homodimerization
(Figures 3A and 7F). Similarly, acetylation of K249 will directly
decrease its intersubunit pairing with E242, as observed for the
IPEX mutant DelK249 (Figures 7G and 7H). Taken together,
acetylation of K251 and/or K249 may impose structural and
functional modifications on the FOXP3 molecules similar to the
IPEX mutations, but in a regulated manner.
Considering the irregularity and instability of the FOXP3 coiled
coil and the potential acetylation sites, we speculate that
acetylation/deacetylation of the coiled-coil regulatory structure
possibly by TIP60 and HDAC7/HDAC9 may reversibly shift the
FOXP3 molecule ensemble between nonstable homodimers
and stable homodimers and heterodimers. From the in vitro
experiment (Figure 3A), we observed that the flexibility of
FOXP3 to have acetylation at K251 is optimal for the formation
of dimer. When K251 is replaced by an acetylation-mimicking
residue K251Q or the negatively charged K251D, formation of
dimer is reduced. A positively charged residue, however, is
preferred at K249 for dimer formation, as no effect is observed
for the K249R mutant.
Acetylation of FOXP3 by discrete signals may have contrast-
ing effects on different lysines. FOXP3 acetylation has been
shown to increase FOXP3 in vivo protein levels by lessening
degradation (van Loosdregt et al., 2010). We found that acetyla-
tion at FOXP3 K249/251 may downregulate its suppressive
activity by causing dimer relaxation. However, TGF-b does not
promote FOXP3 acetylation at K249 and K251 that are domi-
nantly targeted by p300 (Figure 4). These data indicate that lysine
modifications of K249 and K251 lead to ‘‘mechanistic adjust-
ments’’ of the dimeric complex of FOXP3 proteins but are not
relevant to the type of the functional change induced by TGF-b
and the acetylation pattern that cytokine stimulates. In fact other
lysine residues undergo specific acetylation encouraged by
TGF-b, and we propose that those modifications alone or in
combination with other posttranslational modifications are
responsible for increased affinity to chromatin and enhanced
suppressive behavior.
Regulation of FOXP3 Complex through Homoclustering
and Heterotypic Interactions
Our crystallographic study identified a hydrophobic stretch on
the molecular surface of the FOXP3 dimer that may promote
homoclustering (Figure S4). Further solution studies confirmed
that FOXP3 may indeed form high molecular weight clusters
(Li et al., 2007b) (Figures 5B and 5C). FOXP3 homoclustering is
diminished by mutations of the residues on the homodimer
interface that disrupts homodimerization. Homoclustering of
human FOXP3 itself can be modified by HDAC inhibitor treat-
ment (Figure S3), suggesting a physiological role in FOXP3-
mediated suppression of higher order complex formation.
FOXP3 can interact with FOXP1 through the leucine
zipper domain. Specifically, FOXP3 forms heterodimers with
FOXP1 likely via an interface similar to that involved in FOXP3
homodimer formation (Figure 3). FOXP1-FOXP3 heteroasso-ciations may compete with FOXP3 homodimerization and/or
homoclustering and the dynamic balance of discrete forms of
FOXP3 complexes may directly affect its repressor activity
(Figure S5).
Previously we reported that the FOXP3 coiled coil may asso-
ciate with HEAT-SHOCK 70-KD PROTEIN 5 (HSPA5/BiP/
GRP78), as well as with the linker histone H1.5 (Li et al.,
2007c). Lately Su and colleagues found that histone H1.5 and
FOXP3 interact with each other to cooperatively repress IL-2
transcription in human T cells (Mackey-Cushman et al., 2011).
IPEXmutations found in the leucine zipper domain that disrupted
FOXP3 homodimerization abolished FOXP3 binding to histone
H1.5, indicating that heteroassociation between H1.5 and
FOXP3 is dependent on the coiled-coil-mediated homodimeriza-
tion of FOXP3.
Conclusions
We have resolved certain of the atomic features of homo- and
heteroassociation of FOXP3. Clearly, it is the homomeric
FOXP3 dimer assembled with other coregulators and in combi-
nation with discrete posttranslational modifications of discrete
FOXP3 residues, that ultimately alters the conformation and
activity of the FOXP3 protein complex tomodulate Treg function.
Appreciation of the structural features of the FOXP3 coiled coil
explains the actions of many of the mutations involved in human
diseases. FOXP3 are acetylated at several lysines, K8, K382, and
K389 (Tao et al., 2007; Samanta et al., 2008) and K249 and K251
(this work), K262 and K267 (M.I.G., unpublished data). A recent
study on acetylation sites of FOXP3, have found a role for K31
and K267 in the regulation of the suppressive activity of regula-
tory T cells (Kwon et al., 2012). A feature of the Kwon et al. study
that extends our thesis is that K31 and K262 may be targets of
Sirtuin deacetylation. It is also worth noting that discrete acety-
lation sites could be differentially modified by different HATs
depending on distinct stimulations and cellular context, which
may result in differential control of the FOXP3 molecules. Our
current work has focused on the acetylation of only K249 and
K251, and described an atomic explanation for FOXP3 acetyla-
tion at K249/251, which alters the stability of the dimeric complex
of FOXP3 proteins. Knowledge of the structure of enzymatic
modifications on FOXP3 may also be useful for modifying immu-
nity to HER2 tumors in which FOXP3+ cells are relevant (M.I.G,
unpublished data).
EXPERIMENTAL PROCEDURES
The experimental procedures used in this manuscript are briefly described as
below. Supplemental Information contains a complete description with more
details.
Protein Expression and Purification
Proteins used in this study were all expressed in Escherichia coli and purified
by Strep-Tactin affinity column followed by gel filtration. All the mutants used
for immunoprecipitation were made based on the full-length FOXP3.
Crystallographic Studies
Crystals were obtained by mixing equal volumes of sample solution (20 mM
HEPES [pH 7.3], 1 mM TCEP, 0.5% Chaps, and 100 mM NaCl) and well buffer
(100 mM NaAC [pH 4.5] and 1.8 M MgSO4) for hanging drop. Crystals were
croprotected by adding 30% glycerol. Native and multiwavelength anomalousCell Reports 1, 665–675, June 28, 2012 ª2012 The Authors 673
dispersion (selenium) data were collected at BL17U beam line, Shanghai
Synchrotron Radiation Facility (Table S1). Structure determination and
modeling were carried out with standard procedures as previously published
(Brown et al., 2005).
Cell Culture and Immunoprecipitation
293T cells transfected with HA-FOXP3 or FLAG-FOXP3 were prepared for
immunoprecipitation with anti-FLAG antibody, followed by western blot
analysis using anti-HA antibody. The expression levels of the exogenous
FOXP3 proteins were also examined by western blot using anti-HA or anti-
FLAG antibody.
Spectroscopy-LC-MS
10 ml of the IP pull-down solution was diluted with the running buffer of a SDS-
PAGE gel (10% Tris-HEPES-SDS gel) for separation. The gel bands of interest
were identified and isolated for trypsin digestion. After MS data collection,
protein identification was achieved through computer aided searching of the
Swiss-Prot human protein database using SEQUEST.
Biacore Analysis
Binding experiments were performed with the surface plasmon resonance-
based biosensor instrument Biacore 2000 (Biacore), at 25C, essentially as
described before (Berezov et al., 2002). Immobilization of FOXP3 on the sensor
surface was performed following the standard amine coupling procedure ac-
cording to manufacturer’s instructions.
Suppression Assay
In vitro assays of Treg function were performed using MACS-purified CFSE-
labeled CD4+ CD25 T cells from normal C57BL/6 mice as effector cells,
and normal CD4+ CD25+ Tregs or Foxp3-transduced cells as regulatory cells,
with flow cytometric assessment of CFSE dilution at 72 hr and data analysis
using Flowjo 4.2 software (TreeStar) (Tao et al., 2007). The ability of Tregs to
suppress the homeostatic proliferation of Thy1.1+ B6 CD4+CD25 T cells
was assessed by the coinjection, i.v., of 106 cells of each type into B6/RAG2/
mice (Tao et al., 2007).
ACCESSION NUMBERS
The atomic coordinates and structure factors have been deposited in the
Protein Data Bank, http://www.pdb.org (PDB ID 3HSX).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
five figures, and one table and can be found with this article online at
doi:10.1016/j.celrep.2012.04.012.
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative




This work was supported by the 973 program of the Ministry of Science and
Technology of China (2010CB529701, 2012CB910204), the National Institutes
of Health (NIH; 5P01AI073489 and 2R01CA055306 to M.I.G.), the Breast
Cancer Research Foundation (M.I.G.), the National Natural Science Founda-
tion of China (NSFC10979005, NSFC30972702, NIH-NSFC collaborative grant
81161120417), and a Science and Technology Commission of Shanghai
Municipality grant (SMCST09JC1416100). B.L.K. acknowledges NIH GM
15847 and contribution no. 965 from the Barnett Institute for support of this
work.674 Cell Reports 1, 665–675, June 28, 2012 ª2012 The AuthorsReceived: February 8, 2012
Revised: March 20, 2012
Accepted: April 30, 2012
Published online: June 14, 2012
REFERENCES
Bandukwala, H.S., Wu, Y., Feuerer, M., Chen, Y., Barboza, B., Ghosh, S.,
Stroud, J.C., Benoist, C., Mathis, D., Rao, A., and Chen, L. (2011). Structure
of a domain-swapped FOXP3 dimer on DNA and its function in regulatory
T cells. Immunity 34, 479–491.
Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., White-
sell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The
immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
(IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21.
Berezov, A., Chen, J., Liu, Q., Zhang, H.T., Greene, M.I., and Murali, R. (2002).
Disabling receptor ensembles with rationally designed interface peptidomi-
metics. J. Biol. Chem. 277, 28330–28339.
Bettelli, E., Dastrange, M., and Oukka, M. (2005). Foxp3 interacts with nuclear
factor of activated T cells andNF-kappaB to repress cytokine gene expression
and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102, 5138–
5143.
Brown, J.H., Zhou, Z., Reshetnikova, L., Robinson, H., Yammani, R.D., Tobac-
man, L.S., and Cohen, C. (2005). Structure of the mid-region of tropomyosin:
bending and binding sites for actin. Proc. Natl. Acad. Sci. USA 102, 18878–
18883.
Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko,
S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disrup-
tion of a new forkhead/winged-helix protein, scurfin, results in the fatal lym-
phoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73.
Chae, W.J., Henegariu, O., Lee, S.K., and Bothwell, A.L. (2006). The mutant
leucine-zipper domain impairs both dimerization and suppressive function of
Foxp3 in T cells. Proc. Natl. Acad. Sci. USA 103, 9631–9636.
Chatila, T.A., Blaeser, F., Ho, N., Lederman, H.M., Voulgaropoulos, C., Helms,
C., and Bowcock, A.M. (2000). JM2, encoding a fork head-related protein, is
mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin.
Invest. 106, R75–R81.
Chen, C., Rowell, E.A., Thomas, R.M., Hancock, W.W., andWells, A.D. (2006).
Transcriptional regulation by Foxp3 is associated with direct promoter
occupancy and modulation of histone acetylation. J. Biol. Chem. 281,
36828–36834.
Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the
development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.
4, 330–336.
Gambineri, E., Torgerson, T.R., and Ochs, H.D. (2003). Immune dysregulation,
polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome
of systemic autoimmunity caused by mutations of FOXP3, a critical regulator
of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430–435.
Gambineri, E., Perroni, L., Passerini, L., Bianchi, L., Doglioni, C., Meschi, F.,
Bonfanti, R., Sznajer, Y., Tommasini, A., Lawitschka, A., et al. (2008). Clinical
and molecular profile of a new series of patients with immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation
between forkhead box protein 3 expression and disease severity. J. Allergy
Clin. Immunol. 122, 1105–1112, e1.
Godfrey, V.L., Wilkinson, J.E., and Russell, L.B. (1991). X-linked lymphoretic-
ular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379–1387.
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell
development by the transcription factor Foxp3. Science 299, 1057–1061.
Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). An essential role
for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337–342.
Koh, K.P., Sundrud, M.S., and Rao, A. (2009). Domain requirements and
sequence specificity of DNA binding for the forkhead transcription factor
FOXP3. PLoS ONE 4, e8109.
Kwon, H.S., Lim, H.W., Wu, J., Schno¨lzer, M., Verdin, E., and Ott, M. (2012).
Three novel acetylation sites in the Foxp3 transcription factor regulate the
suppressive activity of regulatory T cells. J. Immunol. 188, 2712–2721.
Li, B., Samanta, A., Song, X., Furuuchi, K., Iacono, K.T., Kennedy, S., Katsu-
mata, M., Saouaf, S.J., and Greene, M.I. (2006). FOXP3 ensembles in T-cell
regulation. Immunol. Rev. 212, 99–113.
Li, B., Samanta, A., Song, X., Iacono, K.T., Bembas, K., Tao, R., Basu, S., Riley,
J.L., Hancock, W.W., Shen, Y., et al. (2007a). FOXP3 interactions with histone
acetyltransferase and class II histone deacetylases are required for repression.
Proc. Natl. Acad. Sci. USA 104, 4571–4576.
Li, B., Samanta, A., Song, X., Iacono, K.T., Brennan, P., Chatila, T.A.,
Roncador, G., Banham, A.H., Riley, J.L., Wang, Q., et al. (2007b). FOXP3 is
a homo-oligomer and a component of a supramolecular regulatory complex
disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 19,
825–835.
Li, B., Saouaf, S.J., Samanta, A., Shen, Y., Hancock, W.W., and Greene, M.I.
(2007c). Biochemistry and therapeutic implications of mechanisms involved in
FOXP3 activity in immune suppression. Curr. Opin. Immunol. 19, 583–588.
Lin, W., Haribhai, D., Relland, L.M., Truong, N., Carlson, M.R., Williams, C.B.,
and Chatila, T.A. (2007). Regulatory T cell development in the absence of
functional Foxp3. Nat. Immunol. 8, 359–368.
Lopes, J.E., Torgerson, T.R., Schubert, L.A., Anover, S.D., Ocheltree, E.L.,
Ochs, H.D., and Ziegler, S.F. (2006). Analysis of FOXP3 reveals multiple
domains required for its function as a transcriptional repressor. J. Immunol.
177, 3133–3142.
Mackey-Cushman, S.L., Gao, J., Holmes, D.A., Nunoya, J.I., Wang, R., Unut-
maz, D., and Su, L. (2011). FoxP3 interacts with linker histone H1.5 tomodulate
gene expression and program Treg cell activity. Genes Immun. 12, 559–567.
Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T.,
Miyachi, Y., Tsukada, T., and Sakaguchi, S. (2007). Foxp3 controls regulatory
T-cell function by interacting with AML1/Runx1. Nature 446, 685–689.
Pavletich, N.P., and Pabo, C.O. (1993). Crystal structure of a five-finger
GLI-DNA complex: new perspectives on zinc fingers. Science 261, 1701–
1707.
Qin, S., Cobbold, S.P., Pope, H., Elliott, J., Kioussis, D., Davies, J., and
Waldmann, H. (1993). ‘‘Infectious’’ transplantation tolerance. Science 259,
974–977.
Reynolds, C., Damerell, D., and Jones, S. (2009). ProtorP: a protein-protein
interaction analysis server. Bioinformatics 25, 413–414.
Rudensky, A.Y., and Campbell, D.J. (2006). In vivo sites and cellular mecha-
nisms of T reg cell-mediated suppression. J. Exp. Med. 203, 489–492.
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immu-
nologic self-tolerancemaintained by activated T cells expressing IL-2 receptor
alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance
causes various autoimmune diseases. J. Immunol. 155, 1151–1164.Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z.,
Shimizu, J., Takahashi, T., and Nomura, T. (2006). Foxp3+ CD25+ CD4+
natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Immunol. Rev. 212, 8–27.
Samanta, A., Li, B., Song, X., Bembas, K., Zhang, G., Katsumata, M., Saouaf,
S.J., Wang, Q., Hancock, W.W., Shen, Y., and Greene, M.I. (2008). TGF-beta
and IL-6 signals modulate chromatin binding and promoter occupancy by
acetylated FOXP3. Proc. Natl. Acad. Sci. USA 105, 14023–14027.
Schwartz, R.H. (2005). Natural regulatory T cells and self-tolerance. Nat.
Immunol. 6, 327–330.
Strelkov, S.V., and Burkhard, P. (2002). Analysis of a-helical coiled coils with
the program TWISTER reveals a structural mechanism for stutter compensa-
tion. J. Struct. Biol. 137, 54–64.
Stroud, J.C., Wu, Y., Bates, D.L., Han, A., Nowick, K., Paabo, S., Tong, H., and
Chen, L. (2006). Structure of the forkhead domain of FOXP2 bound to DNA.
Structure 14, 159–166.
Tao, R., de Zoeten, E.F., Ozkaynak, E., Chen, C.,Wang, L., Porrett, P.M., Li, B.,
Turka, L.A., Olson, E.N., Greene, M.I., et al. (2007). Deacetylase inhibition
promotes the generation and function of regulatory T cells. Nat. Med. 13,
1299–1307.
van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Gent, Y.Y., Beekman, J.M.,
van Beekum, O., Brenkman, A.B., Hijnen, D.J., Mutis, T., Kalkhoven, E.,
et al. (2010). Regulation of Treg functionality by acetylation-mediated Foxp3
protein stabilization. Blood 115, 965–974.
Wang, B., Lin, D., Li, C., and Tucker, P. (2003). Multiple domains define the
expression and regulatory properties of Foxp1 forkhead transcriptional
repressors. J. Biol. Chem. 278, 24259–24268.
Wildin, R.S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.L., Buist, N.,
Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked
neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the
human equivalent of mouse scurfy. Nat. Genet. 27, 18–20.
Wildin, R.S., Smyk-Pearson, S., and Filipovich, A.H. (2002). Clinical andmolec-
ular features of the immunodysregulation, polyendocrinopathy, enteropathy, X
linked (IPEX) syndrome. J. Med. Genet. 39, 537–545.
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A.D., Stroud, J.C.,
Bates, D.L., Guo, L., Han, A., Ziegler, S.F., et al. (2006). FOXP3 controls regu-
latory T cell function through cooperation with NFAT. Cell 126, 375–387.
Xiao, Y., Li, B., Zhou, Z., Hancock, W.W., Zhang, H., and Greene, M.I. (2010).
Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg
function. Curr. Opin. Immunol. 22, 583–591.
Ziegler, S.F. (2006). FOXP3: of mice and men. Annu. Rev. Immunol. 24,
209–226.
Zuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y.,
Liu, X., Chan, M.W., et al. (2007). FOXP3 is an X-linked breast cancer
suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.
Cell 129, 1275–1286.Cell Reports 1, 665–675, June 28, 2012 ª2012 The Authors 675
